A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2009
12/15/2009	US7632836 2-Morpholinoethyl ester of pivagabine; improved pharmacokinetic and therapeutic profiles; bioavailability; dosage; brain disorders; behavioral disorders; antidepressants; anxiolytic agents; neurodegenerative disorders; analgesics; eating disorders; antiarthritic agents; bipolar disorders; dysthymia
12/15/2009	US7632813 Administering N-(3-{2-[3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-tetrahydro-2H-pyran-4-ylpropyl)cycloheptanecarboxamideas an inhibitor and a type of parathyroid hormone to treat and/orprevent bone metabolic diseases
12/15/2009	CA2403110C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
12/15/2009	CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/15/2009	CA2361635C Methods and compositions for healing and repair of articular cartilage
12/15/2009	CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/10/2009	WO2009149370A1 Methods for the treatment of rheumatoid arthritis
12/10/2009	WO2009148874A2 Gamma-lactam compounds for promoting bone growth
12/10/2009	WO2009148620A2 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
12/10/2009	WO2009148566A2 Development of a c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis
12/10/2009	WO2009148052A1 Sulfonamide compound and application thereof
12/10/2009	WO2009147742A1 Sirna of human osteopontin
12/10/2009	WO2009147442A1 Novel treatments
12/10/2009	WO2009147218A1 Pharmaceutical combination
12/10/2009	WO2009147165A1 Novel ep4 receptor agonist compounds
12/10/2009	WO2009146490A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
12/10/2009	US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/10/2009	US20090306141 Novel Compounds
12/10/2009	US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009	US20090306030 Methods Of Inhibiting Osteoclast Activity
12/10/2009	US20090305997 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305983 Curable Bone Cement
12/10/2009	US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
12/10/2009	US20090304830 Composition Comprising Bamboo Extract for Androgen Agonist
12/10/2009	US20090304823 Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
12/10/2009	US20090304807 Method for preparing a prion-free bond grafting substitute
12/10/2009	US20090304775 Drug-Exuding Orthopedic Implant
12/10/2009	US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009	CA2728423A1 Respiratory syncytial virus renders dendritic cells tolerogenic
12/10/2009	CA2727171A1 Methods for the treatment of rheumatoid arthritis
12/10/2009	CA2727018A1 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
12/10/2009	CA2726885A1 Sirna of human osteopontin
12/10/2009	CA2726878A1 Novel treatments
12/10/2009	CA2726662A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
12/10/2009	CA2726644A1 Pharmaceutical combination
12/10/2009	CA2726610A1 Sulfonamide compounds and use thereof
12/09/2009	EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130828A1 Sulfonamide derivative
12/09/2009	EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009	EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2129775A1 Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
12/09/2009	EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/09/2009	EP1981843B1 Vitamin d analog: nel, methods and uses thereof
12/09/2009	EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009	EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/09/2009	EP1472282B1 Use of calmodulin to promote bone regeneration
12/09/2009	EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009	EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009	EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009	CN101600712A Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/09/2009	CN101600420A Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/ or joint disorders
12/09/2009	CN101597324A Decapeptide inhibiting angiogenesis and use thereof
12/09/2009	CN101597272A Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof
12/09/2009	CN101597271A Iguratimod derivatives, preparation method thereof and pharmaceutical use thereof
12/09/2009	CN101596295A Medicinal composition for treating gout and preparation process thereof
12/09/2009	CN101596263A Medicine for treating fracture and preparation method thereof
12/09/2009	CN101596244A External-use medicine for treating rheumatism rheumatoid arthritis
12/09/2009	CN101596216A Microbiological preparation for preventing or treating diabetes and related symptoms
12/09/2009	CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof
12/09/2009	CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same
12/09/2009	CN100567301C Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/09/2009	CN100567253C Novel succinate salt of O-demethyl-venlafaxine
12/09/2009	CN100566742C Chinese medicine preparations for treating hyperosteogeny disease
12/08/2009	US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	US7629363 Diaryl substituted pyridinones
12/08/2009	US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009	US7629341 Human ADAM-10 inhibitors
12/08/2009	US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009	US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009	US7629155 foods and beverages containing 1,4-dihydroxy-2-naphthalene carboxylic acid or salts, used for improving intestinal flora, alleviating abdominal ailments caused by lactose intolerance and for preventing or treating metabolic bone diseases
12/08/2009	US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
12/08/2009	US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/08/2009	US7628988 Induce cell differentiation; process control
12/08/2009	CA2510797C Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2009	CA2440744C Il-12 expression controlling agent
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2419301C Quinazoline derivatives
12/08/2009	CA2415486C Pyramidine derivatives
12/08/2009	CA2404725C Extrusion die
12/08/2009	CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/08/2009	CA2389025C Hormonal composition based on a progesterone and an oestrogen and use thereof
12/08/2009	CA2383054C Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
12/08/2009	CA2375986C Substituted pyrazole compounds
12/08/2009	CA2373183C Iminocyclitol inhibitors of hexoaminidase and glycosidase
12/08/2009	CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009	CA2355075C Heteroaryl-cyclic acetals
12/08/2009	CA2315113C Pyridones as src family sh2 domain inhibitors
12/03/2009	WO2009146033A2 Compositions and methods for modulating smn activity
12/03/2009	WO2009146030A1 Methods and systems for reducing inflammation by neuromodulation of t-cell activity
12/03/2009	WO2009144450A1 Tetrahydrofuro [3, 2-b] pyrrol-3-one derivatives as inhibitors of cysteine proteases
12/03/2009	WO2009144395A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof

1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 820